ArticleJournal of the National Cancer Institute2015

Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia.

Yu-Chou Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.